Journal of Medical Screening > Volume 16, Number 3 > Pp. 119-123

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Abduljabbar, M Articles by Afifi, A PubMed PubMed Citation Social Bookmarking                      What's this?

Original Articles

Is umbilical cord blood total thyroxin measurement effective in newborn screening for hypothyroidism?

M Abduljabbar, Paediatric Endocrinology Attending  , Department of Pediatrics, Saudi Aramco Medical Services Organization, Eastern Province, Saudi Arabia

A Al Shahri, Supervisor, Clinical Laboratory Medicine , Department of Pathology, Saudi Aramco Medical Services Organization, Eastern Province, Saudi Arabia

A Afifi, Neonatal-Perinatal Medicine Attending , Department of Pediatrics, Saudi Aramco Medical Services Organization, Eastern Province, Saudi Arabia

Correspondence to: Dr M Abduljabbar, Saudi Aramco Medical Services Organization (SAMSO), Dhahran 31311, Saudi Arabia; mohammad.abduljabbar.1{at}aramco.com

---

Objective To assess the performance of the use of umbilical cord blood for screening of primary congenital hypothyroidism in the Saudi Aramco Medical Services Organization newborn thyroid screening programme.

Methods Umbilical cord blood total thyroxin (CB-TT4) was measured. In samples with low T4 concentrations, an additional measurement of cord blood thyroid-stimulating hormone was made.

Results A total of 96,015 newborn infants were screened in the period January 1990–December 2007. Twenty-six cases of primary congenital hypothyroidism, six cases of transient hypothyroidism and 13 cases of central hypothyroidism were detected. This method of screening resulted in 100% sensitivity and 98% specificity (95% CI 84–100, and 95% CI 98–98.2, respectively). However, there was a high mean recall rate of 1.9%.

Conclusion The use of CB-TT4 is a valid screening strategy for primary congenital hypothyroidism. It meets the metabolic screening demands of early discharge policy and guarantees screening all newborns delivered in the hospital.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?